Drugging Chromatin in Cancer: Recent Advances and Novel Approaches
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology
Reference102 articles.
1. Harnessing the potential of epigenetic therapy to target solid tumors;Ahuja;J. Clin. Invest.,2014
2. Resveratrol-salicylate derivatives as selective DNMT3 inhibitors and anticancer agents;Aldawsari;J. Enz. Inhibi. Med. Chem.,2015
3. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast;Bachmann;J. Clin. Oncol.,2006
4. BET bromodomain inhibitors in leukemia;Basheer;Exp. Hematol.,2015
5. The NIH Roadmap Epigenomics Mapping Consortium;Bernstein;Nat. Biotechnol.,2010
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pan-cancer landscape of epigenetic factor expression predicts tumor outcome;Communications Biology;2023-11-16
2. DNA mimic foldamers affect chromatin composition and disturb cell cycle progression;Nucleic Acids Research;2023-08-31
3. The histone chaperone FACT: a guardian of chromatin structure integrity;Transcription;2022-04-29
4. Comprehensive Comparative Molecular Characterization of Young and Old Lung Cancer Patients;Frontiers in Oncology;2022-01-12
5. Immunotherapy in hematological malignancies: recent advances and open questions;Immunotherapy;2021-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3